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Summary 
Most cases of cystic fibrosis are caused by mutations 
that interfere with the biosynthetic folding of thecystic 
fibrosis transmembrane conductance regulator (CFTR), 
leading to the rapid degradation of CFTR molecules 
that have not matured beyond the endoplasmic reticu- 
lum (ER). The mechanism by which integral membrane 
proteins including CFTR are recognized and targeted 
for ER degradation and the proteolytic machinery in- 
volved in this process are not well understood. We 
show here that the degradation of both wild-type and 
mutant CFTR is inhibited by two potent proteasome 
inhibitors that induce the accumulation of polyubiqui- 
tinated forms of immature CFTR. CFTR degradation 
was also inhibited by coexpression of a dominant neg- 
ative ubiquitin mutant and in cells bearing a tempera- 
ture-sensitive mutation in the ubiquitin-activating en- 
zyme, confirming that ubiquitination is required for 
rapid CFTR degradation. 
Introduction 
Cystic fibrosis (CF) is a lethal hereditary disorder affecting 
approximately one in two thousand live births among pop- 
ulations of Caucasian or northern European descent. CF is 
caused by the functional absence of a plasma membrane 
chloride channel designated CFTR, for cystic fibrosis 
transmembrane conductance regulator (Welsh and Smith, 
1993). The vast majority of CF cases in these populations 
are linked to a single genetic lesion: deletion of phenylala- 
nine (AF508) from a cytoplasmically localized portion of 
CFTR (Kerem et al., 1990; Tsui, 1992). CFTR protein is 
absent from the plasma membranes of epithelial cells from 
patients homozygous for the AF508 allele (Kartner et al., 
1992) and cultured cells expressing AF508 cDNA (Cheng 
et al., 1990). Unlike wild-type CFTR, which is processed 
by the secretory pathway and delivered to the plasma 
membrane in transfected cells, AF508 is retained and de- 
graded in a pre-Golgi compartment (Cheng et al., 1990; 
Ward and Kopito, 1994; Lukacs et al., 1994). These obser- 
vations have led to the hypothesis that the AF508 mutation 
leads to misfolding of CFTR and consequent retention of 
the misfolded protein by the quality control apparatus in 
the endoplasmic reticulum (ER), resulting in its rapid deg- 
radation by an unknown ER proteolysis pathway (Cheng 
et al., 1990; Ward and Kopito, 1994; Yang et al., 1993). 
Recent studies have indicated that the folding of both 
wild-type and AF508 CFTR is inefficient and that AF508 
molecules are rapidly degraded by a process that is kinet- 
ically and pharmacologically indistinguishable from the 
process involved in the degradation of misfolded wild-type 
immature CFTR (Ward and Kopito, 1994; Lukacs et al., 
1994). Both wild-type and AF508 CFTR are initiallysynthe- 
sized as - 140 kDa core-glycosylated primary translation 
products that are associated with the cytosolic chaperone 
Hsc70 (Yang et al., 1993) and the ER chaperone calnexin 
(Pind et al., 1994), indicating that they span the ER mem- 
brane. A fraction (-250/o-50%) of wild-type CFTR imma- 
ture translation products are released from chaperone 
complexes, suggesting that they fold into a maturation- 
competent form that is rapidly exported to the Golgi appa- 
ratus (Ward and Kopito, 1994; Lukacs et al., 1994). The 
majority (- 75%) of wild-type CFTR precursors, however, 
are rapidly degraded, without apparent lag following trans- 
lation, by a process that is insensitive to inhibitors of lyso- 
somal proteolysis and brefeldin A (Ward and Kopito, 1994; 
Lukacs et al., 1994), suggesting that it occurs in a pre-Golgi 
compartment. By contrast with wild-type CFTR, the vast 
majority (>99%) of immature, core-glycosylated AF508 
precursors are not released from chaperone complexes 
(Yang et al., 1993; Pind et al., 1994), fail to acquire com- 
plex N-linked glycans, indicative of transit through the 
Golgi apparatus, and are degraded with kinetics identical 
to those of wild type (Ward and Kopito, 1994; Lukacs et 
al., 1994). When overexpressed, AF508 precursors accu- 
mulate in association with ER membranes (Yang et al., 
1993). These data collectively suggest a model in which 
immature wild-type or AF508 CFTR molecules that fail to 
fold correctly are sorted to a degradation pathway that is 
ill defined but appears to have many properties in common 
with previously described ER degradation (Klausner and 
Sitia, 1990; Fra and Sitia, 1993). The effect of the AF508 
mutation is to increase the proportion of nascent CFTR 
molecules that leave the folding pathway and, hence, are 
targeted for degradation. 
In cultured cells, the AF508 block to maturation can be 
partially overcome by incubation at reduced temperatures 
or overexpression (Dalemans et al., 1991; Denning et al., 
1992; Drumm et al., 1991), giving rise to cell surface 
AF508 molecules that form functional, CAMP-activated 
chloride channels. These data further confirm that the 
AF508 mutation does not necessarily interfere with the 
function of CFTR, but serves to target it to the ER degrada- 
tion apparatus. Therefore, strategies aimed at blocking 
the degradation of this mutant protein have been proposed 
as potential therapeutics in CF management (Cheng et 
al., 1990). The data in this paper suggest that such strate- 
gies are unlikely to be effective. We show that lactacystin, 
a potent and apparently highly specific inhibitor of the 20s 
proteasome, blocks the degradation of immature wild-type 
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Figure 1. CFTR Degradation Is Inhibited by Inhibitors of the 20s Pro- 
teasome 
Wild-type CFTR-expressing cells were incubated overnight alone 
(lanes I), with ALLN (lanes 2) or with lactacystin (lanes 3-6), at the 
concentrations indicated (in micromolar), separated into detergent- 
soluble (top) and insoluble (bottom) material, and immunoblotted with 
CFTR antibody. Arrow indicates mobility of immature core-glyco- 
sylated form (140 kDa). Arrowhead indicates mobility of mature com- 
plex-glycosylated form (160 kDa). 
and AF508 CFTR molecules. Inhibition of CFTR or AF508 
proteolysis leads to the accumulation of polyubiquitinated 
forms of immature CFTR that though undegraded are 
blocked from maturation into a functional post-ER com- 
partment. Our  data demonstrate that polyubiquitination 
serves to direct the degradation of CFTR. 
Results 
inhibitors of the 20s Proteasome Induce the 
Accumulation of Detergent-Insoluble Forms 
of Wild-Type and AF508 CFTR 
The effect of protease inhibitors on the steady-state levels 
of mature (complex-glycosylated) 160 kDa and immature 
(core-glycosylated) 140 kDa CFTR was assessed by im- 
munoblot analysis of HEK cells expressing wild-type 
CFTR. Although inhibitors of papain, trypsin, chymotryp- 
sin, and lysosomal cathepsins did not significantly affect 
CFTR expression in detergent-soluble or insoluble frac- 
tions (data not shown), N-acetyl-L-leucinyl-L-leucinyl-L- 
norleucinal (ALLN) and lactacystin, both potent inhibitors 
of the 20s proteasome, led to an -50-fold increase in 
steady-state levels of core-glycosylated, immature (140 
kDa) CFTR (Figure 1). This accumulation is consistent with 
inhibition of the normally rapid (tIjs < 30 min) degradation 
of CFTR precursors in a pre-Golgi compartment (Ward 
and Kopito, 1994; Lukacs et al., 1994). However,  the pro- 
teasome inhibitors failed to increase expression of the ma- 
ture (complex-glycosylated) form of CFTR, despite the in- 
crease in its apparent precursor, suggesting that immature 
CFTR molecules that are destined for degradation exist 
in a form that is not competent for export to the Golgi 
apparatus. Indeed, nearly all of the spared CFTR- 
immunoreactive material was insoluble in nonionic deter- 
gent and was frequently accompanied by the appearance 
of a high molecular weight smear punctuated by discrete 
bands (Figure 2A). 
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Figure 2. CFTR Is Polyubiquitinated In Vivo 
(A) Ladder of wild-type (lanes 1-2) and AF506 (lanes 3-4) CFTR immu- 
noreactive bands detected by immunoblotting with affinity-purified 
CFTR antibody. HEKcells, transfected as indicated, were treated over- 
night with ALLN (100 pglml) prior to lysis and separation into soluble 
(s) and insoluble (i) fractions. 
(B) lmmunoprecipitation of ubiquitin-immunoreactive polypeptides 
with CFTR antibody. Control (vector-transfected, lanes 1-4) and 
AF506 CFTR-transfected (lanes 5-8) cells, treated with (lanes 3, 4, 
7, and 6) or without (lanes 1, 2, 5, and 6) ALLN, were solubilized in 
detergent and separated into detergent-soluble (s) and insoluble (i) 
fractions. CFTR immunoprecipitates were separated on 7% SDS- 
polyacrylamide gels and immunoblotted with a polyclonal ubiquitin 
antibody. 
(C) High-molecular weight forms of CFTR are modified by epitope- 
tagged ubiquitin. HEK cells were transfected with HsM-Ub (lanes 
1-2) or AF506 CFTR (lanes 3-4) or cotransfected (at a 1O:l ratio) with 
both (lanes 5-6). Lysates were prepared, and the detergent-insoluble 
fractions were immunoprecipitated (after solubilization in SDS and 
dilution) with affinity-purified CFTR antibody. Duplicate samples (in 
pairs of lanes) of immunocomplexes were separated on 7.5% SDS- 
polyacrylamide gels and detected by immunoblotting with either c-Myc 
MAb (upper panel) or with CFTR antibody. 
(D) Specific binding of ubiquitinated CFTR to Ni-NTA resin. Fractions 
from HEK cells expressing AF506 CFTR alone (lanes 1-6) or cotrans- 
fected with HsM-Ub (lanes 7-12) fractionated on Ni-NTA resin as de- 
scribed in Experimental Procedures. Samples of total lysate (t), flow- 
through unbound material (f), and bound, eluted material (b), each 
representing equivalent fractions of the original ceil lysate, were elec- 
trophoresed and immunoblotted with CFTR antibody. 
Insoluble CFTR and AF508 Are Polyubiquitinated 
Closer examination of immunoblotsof insoluble CFTR and 
AF508 reveal that the immunoreactive smear can often 
be resolved into a ladder of bands spaced at 6.48 + 0.45 
(n = 7) kDa intervals (Figure 2A). Such a ladder of bands 
regularly spaced at - 7 kDa intervals is a hallmark of poly- 
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ubiquitination and reflects covalent attachment of multiple 
ubiquitin chains that serve as a degradation signal for the 
target protein (reviewed by Ciechanover, 1994). To test 
directly the hypothesis that CFTR is modified by ubiquiti- 
nation, cells transfected with vector or with AF508 CFTR 
were immunoprecipitated with affinity-purified antibody to 
CFTR and immunoblotted with a polyclonal antibody to 
ubiquitin (Figure 28). No ubiquitin immunoreactivity was 
detected in samples from control cells not expressing 
CFTR (lanes l-4). By contrast, ubiquitin immunoreactivity 
was present in detergent-soluble and insoluble fractions 
from cells expressing AF508 CFTR (lanes 5-8); this signal 
increased significantly in ALLN-treated cells. 
To characterize ubiquitinated proteins in transfected 
HEK cells, an NHP-terminal HISS- and c-Myc epitope- 
tagged ubiquitin (HEM-Ub) was coexpressed together with 
wild-type or AF508 CFTR. Approximately 50% of total ubi- 
quitin in HEK cells expressing this construct was esti- 
mated by immunoblotting to contain the c-Myc epitope 
(data not shown). ALLN treatment of HsM-Ub-transfected 
cells induced a massive increase in the steady-state level 
of detergent-soluble and insoluble ubiquitinated proteins 
(as judged from the level of c-Myc immunoreactivity [data 
not shown]), confirming that ALLN, a potent inhibitor of 
the 20s proteasome (Rock et al., 1994), inhibits the degra- 
dation of ubiquitinated proteins in HEK cells. To confirm 
that undegraded CFTR is also modified by polyubiquitina- 
tion, cotransfected cells and control cells expressing 
AF508 CFTR or HsM-Ub, individually, were treated with 
and without ALLN and separated into detergent-soluble 
and insoluble fractions. The insoluble fraction was immu- 
noprecipitated with CFTR antibody (after solubilization in 
1 O/O SDS and dilution of the SDS) and the immunoprecipi- 
tates subjected to immunoblotting with CFTR antibody 
(Figure 2C, bottom) or c-Myc monoclonal antibody (MAb) 
(Figure 2C, top). Strikingly, when the immunoprecipitates 
were probed with a c-Myc MAb, strong immunoreactivity 
was observed as a smear of high molecular weight mate- 
rial from cells that were cotransfected with both HsM-Ub 
and AF508 CFTR, but not from cells transfected with either 
CFTR or H6M-Ub alone. 
Ubiquitinated (HBM-Ub) CFTR was also detected by NP 
chelation chromatography (Figure 2D). Binding of CFTR 
that was not tagged with HisG, i.e., from cells transfected 
only with AF508, to a nickel-nitrilotriacetic acid (Ni-NTA) 
column was negligible (lanes 3 and 6), indicating that the 
binding conditions used were stringent enough to ensure 
specificity for Hiss-tagged proteins. By contrast, a signifi- 
cant fraction of AF508 from cotransfected cells bound to 
the column and was eluted with 1 .O M  imidazole (lanes 9 
and 12). Some of the detergent-soluble CFTR-immunore- 
active material that bound to and was eluted from the Ni- 
NTAcolumn migrated with the mobility of immature CFTR. 
This could suggest either that a fraction of AF508 was 
modified with short ubiquitin chains, or that some polyubi- 
quitinated AF508 became deubiquitinated. However, 
nearly all of the material from the detergent-insoluble frac- 
tion that bound to and was eluted from the column mi- 
grated in the high molecular weight region of the gel, con- 
sistent with modification by longer ubiquitin chains. 
Similarly, when wild-type CFTR was coexpressed together 
with HsM-Ub, immature and high molecular weight, but 
not mature, forms of the protein were bound to and eluted 
from the Ni-NTA column (data not shown). Taken to- 
gether, these data strongly suggest that a fraction of CFTR 
and AF508 in HEK cells is polyubiquitinated in vivo and 
degraded by a ubiquitin-linked pathway. 
Rapid Degradation of CFTR 
Requires Polyubiquitination 
To demonstrate that polyubiquitination is required for 
CFTR and AF508 degradation, we coexpressed AF508 
with a dominant negative ubiquitin mutant, K48R. The 
s-amino group of the invariant Lys-48 residue of one ubi- 
quitin molecule is the site of isopeptide linkage of other 
ubiquitin molecules and is essential for the formation of 
multiubiquitin chains (Chau et al., 1989; Finley et al., 
1994). Expression of mutant ubiquitin in which this invari- 
ant lysine has been replaced by arginine (K48R) has a 
chain-terminating, dominant negative effect (Chau et al., 
1989; Finley et al., 1994). Coexpression of AF508 and 
wild-type HBM-Ub in HEK cells did not inhibit the degrada- 
tion of AF508 (Figure 3A). By contrast, we observed a 
massive increase in both soluble and insoluble AF508 in 
cells coexpressing AF508 and HeM-K48R. These data in- 
dicate that the K48R mutant ubiquitin blocks AF508 CFTR 
degradation and suggest that ubiquitination is required for 
CFTR degradation. 
If CFTR degradation requires polyubiquitination, then 
K48R coexpression would be predicted to slow the kinetics 
of the rapid degradation of core-glycosylated CFTR. To 
test this prediction, HEK cells expressing AF508 alone or 
in combination with wild-type HsM-Ub or HsM-Ub(K48R) 
were pulse-labeled with [%S]methionine for 15 min, then 
chased with excess unlabeled methionine for the times 
indicated (Figure 3B). In control cells transfected with 
AF508 alone (lanes l-4) or together with wild-type HsM-Ub 
(lanes 5-8), label in the 140 kDa core-glycosylated imma- 
ture AF508 primary translation product decayed rapidly 
from the soluble pool. After a 3 hr chase, approximately 
10% of the label originally incorporated into immature 
AF508 in control cells was recovered in the soluble frac- 
tion. Since less than 5% of the incorporated label appeared 
in the insoluble fraction, the data confirm that degradation 
accounts for the raprd (t,,*, -30 min) disappearance of 
labeled, soluble core glycosylated CFTR and AF508 mole- 
cules (Ward and Kopito, 1994). The kinetics of AF508 turn- 
over in cells coexpressing K48R ubiquitin differed from 
the controls in two important respects. First, the absolute 
amount of [%I incorporated into immature AF508 during 
the pulse was approximately 4- to 5fold higher than in the 
controls (compare lanes 9 and 1). This effect was appar- 
ently not due to increased label incorporation into imma- 
ture CFTR, as the cells were transfected with equivalent 
amounts of plasmid, and the samples taken for immuno- 
precipitation were normalized to the level of total protein 
synthesis. Moreover, we consistently observe a similar 
increase in labeling of soluble immature CFTR at the end 
of a 15 min pulse when the pulse is performed in the pres- 
ence of ALLN (data not shown). The data suggest that, 
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Figure 3. CFTR Degradation Is Inhibited by 
Dominant Negative Ubiquitin 
B (A) Effect of coexpression of HsM-Ub K48R on steady-state AF508 CFTR levels. Cells were 
No Ubiquitin WI H,M-“II K4sR transfected with AF508 CFTR alone (lanes 1) 
orcotransfected (at a 1O:l ratioof Ub to AF508) 
with either wild-type HsM-Ub (lanes 2) or 
HsM-Ub in which Lys-48 was substituted with 
arginine (K48R; lanes 3). Samples were solubi- 
lized, separated into detergent-soluble (top) or 
insoluble (bottom) fractions, and immunoblot- 
ted with CFTR antibody. 
12 34 
(6) Effect of coexpression of HsM-Ub K48R on 
5678 91 the kinetics of AF508 CFTR turnover. HEK 
cells were transfected with AF508 CFTR alone 
(lanes 1-4) or cotransfected (as above) with 
either wild-type HsM-Ub (lanes 5-8) or H6M-Ub 
1 2 3 K48R (lanes 9-12). Cells were pulse-labeled 
with [?S]methionine for 15 mi n and chased with 
excess unlabeled methionine for the times indicated. At each timepoint cells were lysed and separated into detergent-soluble (upper panel) and 
insoluble (lower panel) material prior to immunoprecipitation. lmmunoprecipitates were then separated by SDS-polyacrylamide gel electrophoresis 
and visualized by fluorography. 
in the absence of ALLN or K48R coexpression, a large 
fraction of labeled soluble immature CFTR is rapidly de- 
graded, even during the 15 min pulse. 
The second effect of K48R coexpression was on the 
fraction of label entering the insoluble pool. Despite the 
greater amount of label following the pulse in the K48R 
cells, the fraction of label present as soluble immature 
CFTR after a 3 hr chase was comparable to that of controls 
(- 10%). Strikingly, however, in contrast with controls, a 
significant fraction of label in the K48R cotransfected cells 
was chased into the detergent-insoluble pool, both as in- 
soluble protein with the mobility of core-glycosylated 
CFTR and as a high molecular weight smear. Because of 
this heterogeneity, it was not possible to quantitate accu- 
rately the amount of label entering the insoluble pool. We 
estimate by phosphorimage analysis of the gel that the 
majority (>70%) of the label leaving the soluble pool was 
recovered after a 3 hr chase in the insoluble fraction. This 
estimate is necessari ly an underestimate, as the mutant 
ubiquitin accounts for only -50% of the total ubiquitin. 
Together, these data indicate that coexpression of a domi- 
nant negative ubiquitin mutant effectively blocks the rapid 
degradation of core-glycosylated AF508. 
Ubiquitin-protein conjugation and protein degradation 
are reduced in ts20 cells incubated at the nonpermissive 
temperature (40%) (Kulka et al., 1988). This mutant cell 
line contains a thermolabile form of the ubiquitin-activating 
enzyme El that is irreversibly inactivated at elevated tem- 
perature (Kulka et al., 1988). Mutant (ts20) and wild-type 
(E36) cells were transfected with CFTR or AF508 cDNA 
and selected for stable expression. Expression of CFTR- 
immunoreactive material was assessed by immunoblot- 
ting of ceil extracts grown for 24 hr at the permissive (31 “C) 
or the nonpermissive (40%) temperature (Figure 4). Strik- 
ingly, the accumulation of CFTR or AF508 was increased 
dramatically when cells were incubated at the nonpermis- 
sive temperature. The simplest interpretation of these re- 
sults is that a functional ubiquitin pathway is required for 
degradation of mutant and wild-type CFTR. Similar results 
were observed in several independently isolated E36 and 
ts20 clones, suggesting that the data are not clonal arti- 
facts. Moreover, the expression level of CFTR and AF508 
is at least lOO-fold lower in these stable lines than in the 
transiently transfected HEK cells, suggesting that the role 
of ubiquitination in CFTR degradation is not peculiar to 
HEK cells, nor is it likely to be a consequence simply of 
overexpression. 
Discussion 
Protein degradation is an important means by which cells 
control the activities of normal proteins and, in conjunction 
with molecular chaperones that comprise the quality con- 
trol apparatus, by which they avoid the potentially toxic 
effects of mutant, denatured, or misfolded polypeptides. 
Two major proteolytic systems have been described in 
eukaryotic cells (reviewed by Olson and Dice, 1989). Lyso- 
somal (or, in yeast, vacuolar) proteases are principally in- 
volved in the degradation of proteins, including plasma 
membrane proteins and exogenous polypeptides, en- 
wildtype AF508 
ts20 E36 E36- ts20 
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Figure 4. Accumulation of CFTR and AF508 in El Mutant Cells 
El mutant ts20 cells (lanes 3-4 and 7-8) or parental E36 cells (lanes 
l-2 and 5-6) stably expressing CFTR (lanes l-4) or AF508 (lanes 
5-8), were incubated for 24 hr at the permissive (31 OC, odd-numbered 
lanes) or the nonpermissive (40°C, even-numbered lanes) tempera- 
ture. Cells were harvested and immunoblotted with CFTR antibody 
as described in the legend to Figure 1. 
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gaged by the endocytic apparatus. Most short-l ived cyto- 
solic proteins are degraded by the 26s proteasome com- 
plex, which contains the multicatalytic 20s proteasome 
as its catalytic core and requires prior covalent attachment 
of multiple ubiquitin chains to the substrate (reviewed by 
Goldberg and Rock, 1992; Ciechanover, 1994). The deg- 
radation of proteins retained by the quality control appara- 
tus in the ER has been proposed to be mediated by 
a third, distinct, ER proteolytic pathway (reviewed by 
Klausner and Sitia, 1990; Fra and Sitia, 1993). The data 
presented here constitute evidence in animal cells that 
the ubiquitin pathway participates in the degradation of a 
short-l ived integral membrane glycoprotein and suggest 
a mechanism by which the ER quality control apparatus 
may be coupled to the intracellular proteolysis machinery. 
Several lines of evidence support our conclusion that 
CFTR is degraded by the proteasome in a ubiquitin- 
dependent manner. First, inhibitors of the 20s protea- 
some, including ALLN and the recently identified com- 
pound lactacystin, interfere with CFTR degradation and 
lead to the accumulation of high molecularweight, polyubi- 
quitinated forms of CFTR. Lactacystin, a Streptomyces 
metabolite, is a potent inhibitor of the trypsin-like, chymo- 
trypsin-like peptidyl-glutamyl peptide-hydrolyzing activi- 
ties of purified 20s proteasome in vitro (Fenteany et al., 
1995). Lactacystin specifically labels the highly conserved 
NH*-terminal threonine residue on the mammalian protea- 
some subunit X that, from the recently solved X-ray struc- 
ture of the archaebacterial proteasome (Lowe et al., 1995) 
is proposed to be the active site nucleophile (Fenteany et 
al., 1995). Interestingly, the aldehyde function of ALLN, 
bound to the active site in the X-ray crystal structure, is 
situated in close proximity to and has been suggested to 
form a hemiacetal with hydroxyl of this threonine (Lowe 
et al., 1995). Although ALLN and related peptide aldehyde 
compounds are also potent proteasome inhibitors, they 
are less specific, exhibiting significant activity in inhibiting 
the cysteine proteases calpain and cathepsin B (Rock et 
al., 1994). By contrast, lactacystin is reported to have no 
detectable effect, even upon extended exposure, on these 
or other cysteine proteases or on the serine proteases 
trypsin and chymotrypsin (Fenteany et al., 1995). While 
these data cannot anticipate other uncharacterized or un- 
discovered proteases against which lactacystin may be 
active, these inhibitor studies support our conclusion that 
the proteasome is involved in CFTR degradation. 
A second line of evidence is our demonstration that 
CFTR is ubiquitinated in vivo. Ubiquitin- and epitope- 
tagged ubiquitin were detected in CFTR immunoprecipi- 
tates, and CFTR-immunoreactive polypeptides were iso- 
lated by metal chelation chromatographyonlyfrom lysates 
of cells expressing both CFTR and Hiss-tagged ubiquitin. 
While these observations support the conclusion that poly- 
ubiquitination is a signal for CFTR degradation, they do 
not formally exclude the possibility that CFTR polyubiquiti- 
nation is the consequence of inhibiting degradation. To 
address this issue, we coexpressed with AF508 CFTR a 
form of ubiquitin containing a mutation in the invariant 
Lys-48. Ubiquitin molecules bearing this mutation can co- 
valently attach to target proteins (including wild-type ubi- 
quitins), but since they lack the s-amino group required 
for isopeptide linkage of additional ubiquitin units, they 
are predicted to exert a chain-terminating effect on the 
formation of extended multiubiquitin chains. Expression 
of these mutants, therefore, has a dominant negative ef- 
fect on polyubiquitination, and hence, on degradation 
(Chau et al., 1989; Finley et al., 1994). Our  data show that 
coexpression of K48R, but not wild-type ubiquitin, drasti- 
cally slowed the kinetics of CFTR degradation, confirming 
that ubiquitination is required for rapid CFTR proteolysis. 
This conclusion is also strongly supported by the observa- 
tion that CFTR and AF508 accumulate, at the nonpermis- 
sive temperature, in ts20 cells that lack the ubiquitin- 
activating enzyme El (Kulka et al., 1988). 
Finally, the results from ts20cells, which express at least 
lOO-fold lower levels of CFTR than do HEK cells, also 
argue that our data are unlikely to be an artifact of HEK 
cell overexpression. We also observe a similar effect of 
lactacystin and ALLN on CFTR and AF508 degradation 
in stably transfected Cl27 mammary carcinoma cells 
(data not shown), which also express considerably lower 
CFTR levels (Marshall et al., 1994; Ward and Kopito, 
1994). These data unambiguously demonstrate that poly- 
ubiquitination of both CFTR and AF508 is linked to rapid 
proteolysis; it is likely that the ubiquitinated forms of CFTR 
and AF508 are degraded in a proteasome-mediated 
fashion. 
Degradation of membrane-spanning proteins such as 
CFTR by the proteasome presents a potential topological 
problem in that the known components of the ubiquitin- 
proteasome pathway are associated with the cytosolic 
compartment (Goldberg and Rock, 1992; Ciechanover, 
1994). It is, however, important to note that CFTR, like 
manyintegral membraneproteins, hasalargecytoplasmic 
domain. Indeed, this domain (which is predicted from to- 
pology models [Riordan et al., 19891 to constitute - 60% of 
CFTR mass) is the site of CF-causing mutations such as 
AF508, and the probable site of attachment of the cytosolic 
chaperone Hsc70 (Yang et al., 1993). It is likely, then, that 
misfolding within this cytosolic domain serves as a signal 
for ubiquitin attachment, perhaps by ubiquitin-conjugating 
machinery associated with the cytosolic face of the ER 
membrane. The ubiquitin-conjugating enzyme UBC6 has 
been reported to be an integral component of the Saccha- 
romyces cerevisiae ER membrane, with its catalytic do- 
main facing the cytosol (Sommer and Jentsch, 1993). It 
is reasonable to expect that other components of the ubi- 
quitin conjugation apparatus, including mammalian homo- 
logs of this yeast enzyme, will be identified in the ER of 
mammalian cells. We propose that recognition by such a 
pathway of misfolded cytosolic domains of integral mem- 
brane proteins could serve to initiate the degradation of 
misfolded CFTR as well as perhaps other integral mem- 
brane proteins that are also known to be degraded in a 
pre-Golgi compartment. Most substrates for ER degrada- 
tion identified to date are integral membrane proteins with 
at least one lysine residue in the putative cytoplasmic do- 
main. It is noteworthy that deletion of the cytosolic and 
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membrane domains of at least one such ER-restricted 
short-l ived protein, the a subunit of T cell receptor, abol- 
ishes its rapid degradation without influencing its retention 
in the ER (Shin et al., 1993). 
Our  data suggest that inhibition of proteasome-medi- 
ated AF508 proteolysis is not likely to be an effective ther- 
apy for treating AF508. Similarly, although dominant neg- 
ative ubiquitin coexpression effectively inhibits CFTR 
degradation, it induces the accumulation of insoluble 
forms of CFTR and does not appear to increase the accu- 
mulation of soluble, mature CFTR. Although immature 
AF508 accumulates in ts20 cells incubated at the nonper- 
missive temperature, there is no accompanying increase 
in AF508 maturation. These data suggest that ubiquitina- 
tion alone cannot be the event that commits immature 
AF508 to the degradation pathway. Additional studies will 
be required to elucidate the involvement of molecular 
chaperones and ubiquitin in determining the fate of na- 
scent CFTR molecules. 
Experimental Procedures 
Plasmids, Cells, and Materials 
cDNA encoding Hiss-, c-Myc-tagged human ubiquitin was generated 
by polymerase chain reaction using pUB221, a gift from D. Finley, as 
the template. The ubiquitin K48R mutant construct was generated by 
the megaprimer method (Landt et al., 1990; Sarkar and Sommer, 
1990). Both ubiquitin constructs were sequenced to verify that no er- 
rors had been introduced. Lactacystin was prepared as previously 
described (Omura et al., 1991). The polyclonal anti-ubiquitin antibody 
was a gift from A. Haas. HEK 293 cells were maintained and 
transfected as previously described (Lee et al., 1991). Mutant ts20 
cells and the parental line E36 (Kulka et al., 1966) (provided by K. 
Rock)were maintained in RPM1 medium supplemented with 10% fetal 
bovine serum. The cellswere transfected by lipofection with CFTR and 
AF508 cDNA inserted into the expression vector RC/CMV(Invitrogen). 
Following lipofection, cells were cultured in RPM1 medium supple- 
mented with G418 (I mglml) at 31 OC. Clonal colonies were isolated, 
expanded, and assayed for CFTR expression by immunoblotting. 
CFTR expression levels in these cells were estimated to be lOO- to 
200-fold lower than in transiently transfected HEK cells. 
lmmunoblotting 
Cell pellets from washed and transfected HEK cells were lysed in 250 
~1 of ice-cold buffer (10 mM Tris-HCI [pH 7.5],5 mM EDTA, 1% Triton 
X-100) plus protease inhibitors (100 PM TLCK, 100 KM TPCK, 1 mM 
PMSF) for 30 min on ice. Insoluble material was recovered by centrifu- 
gation at 13,000 x g for 15 min at 4OC and solubilized in SDS sample 
buffer. DNA was sheared by repeated passage of the sample through 
a 25gauge needle. Cell fractions, normalized for total protein, were 
separated on 7% SDS-polyacrylamide gels and electroblotted. Chem- 
iluminescent detection was carried out with the Renaissance detection 
kit (New England Nuclear). 
Nickel Affinity Chromatography 
Cells were transfected and harvested as described above. Insoluble 
pellets were solubilized in 25-50 ~1 of 1% SDS, 10 mM Tris-HCI [pH 
7.51, 10% glycerol for 10 min at 65’C, diluted to 1 ml with lysis buffer, 
sonicated for20s, and then respun. Thesolubleand insolublefractions 
were mixed with 50 VI of a 50% slurry of Ni-NTA resin for 16-20 hr 
at 4’%  followed by three washes in lysis buffer. Bound material was 
eluted in 50-100 ~1 of 50 mM sodium phosphate (pH 6.0), 150 mM 
NaCI, 1% Triton X-100 containing 1 M  imidazole. Volumes loaded 
on SDS-polyacrylamide gels represented equivalent fractions of the 
original cell lysate. Gels were immunoblotted as described above. 
Pulse-Chase Experiment 
Cells were pulse-labeled with [%]methionine/cysteinefor 15 min, har- 
vested, and immunoprecipitated as previously described (Ward and 
Kopito, 1994). Loading volumes were normalized to the sample with 
the lowest trichloroacetic acid-precipitable cpm. Following electropho- 
resis, the radiolabeled bands were imaged and quantified with a phos- 
phorimager (Molecular Dynamics). 
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